Cargando…
A Novel DNA Vaccine Technology Conveying Protection against a Lethal Herpes Simplex Viral Challenge in Mice
While there are a number of licensed veterinary DNA vaccines, to date, none have been licensed for use in humans. Here, we demonstrate that a novel technology designed to enhance the immunogenicity of DNA vaccines protects against lethal herpes simplex virus 2 (HSV-2) challenge in a murine model. Po...
Autores principales: | Dutton, Julie L., Li, Bo, Woo, Wai-Ping, Marshak, Joshua O., Xu, Yan, Huang, Meei-li, Dong, Lichun, Frazer, Ian H., Koelle, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789751/ https://www.ncbi.nlm.nih.gov/pubmed/24098493 http://dx.doi.org/10.1371/journal.pone.0076407 |
Ejemplares similares
-
An escalating dose study to assess the safety, tolerability and immunogenicity of a Herpes Simplex Virus DNA vaccine, COR-1
por: Dutton, Julie L., et al.
Publicado: (2016) -
1224 Defining herpes simplex virus type 2 sequence heterogeneity using next generation sequencing
por: Johnston, Christine, et al.
Publicado: (2014) -
Structure of the herpes simplex virus portal-vertex
por: McElwee, Marion, et al.
Publicado: (2018) -
Decision-making in Herpes Simplex viral keratitis grafts
por: Natarajan, Radhika, et al.
Publicado: (2023) -
Trillions and Trillions: Herpes Simplex Virus–1 Hepatitis in an Immunocompetent Adult
por: Ikuta, Kevin, et al.
Publicado: (2019)